semaglutide feeling faint Guide to Side Effects and How to Manage Them Semaglutide and Dizziness: Causes and

[4] Together, the obesity and diabetes trials give retatrutide the broadest Phase 2 metabolic dataset of the two compounds, and the program has extended into hepatic (liver-fat / MASLD) and cardiometabolic questions that reflect the glucagon arms biology

The nutritional guidelines for GLP-1 treatment apply equally to semaglutide users and emphasize protein-forward eating

By reducing fat mass and improving adipose tissue signaling, retatrutide may: Lower inflammatory cytokines Improve adipose tissue health Reduce metabolic stress on the liver, pancreas, and cardiovascular system These effects support broader metabolic improvement beyond cosmetic weight loss

Kievit P, et al